198 related articles for article (PubMed ID: 19193669)
1. Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes.
Mengshol JA; Golden-Mason L; Castelblanco N; Im KA; Dillon SM; Wilson CC; Rosen HR;
Gut; 2009 Jul; 58(7):964-73. PubMed ID: 19193669
[TBL] [Abstract][Full Text] [Related]
2. Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon.
Cicinnati VR; Kang J; Sotiropoulos GC; Hilgard P; Frilling A; Broelsch CE; Gerken G; Beckebaum S
J Gen Virol; 2008 May; 89(Pt 5):1243-1253. PubMed ID: 18420803
[TBL] [Abstract][Full Text] [Related]
3. Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy.
Simone O; Tortorella C; Zaccaro B; Napoli N; Antonaci S
J Clin Immunol; 2010 Jul; 30(4):556-65. PubMed ID: 20390327
[TBL] [Abstract][Full Text] [Related]
4. Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C.
Crosignani A; Riva A; Della Bella S
World J Gastroenterol; 2016 Jan; 22(4):1393-404. PubMed ID: 26819508
[TBL] [Abstract][Full Text] [Related]
5. Functional reconstitution of defective myeloid dendritic cells in chronic hepatitis C infection on successful antiviral treatment.
Rana D; Chawla YK; Duseja A; Dhiman R; Arora SK
Liver Int; 2012 Aug; 32(7):1128-37. PubMed ID: 22309109
[TBL] [Abstract][Full Text] [Related]
6. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection.
Tomer S; Chawla YK; Duseja A; Arora SK
World J Gastroenterol; 2016 Jun; 22(22):5173-82. PubMed ID: 27298560
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.
Liang H; Russell RS; Yonkers NL; McDonald D; Rodriguez B; Harding CV; Anthony DD
J Virol; 2009 Jun; 83(11):5693-707. PubMed ID: 19297478
[TBL] [Abstract][Full Text] [Related]
8. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection.
Velazquez VM; Hon H; Ibegbu C; Knechtle SJ; Kirk AD; Grakoui A
Hepatology; 2012 Dec; 56(6):2071-81. PubMed ID: 22711645
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses.
Athanassopoulos P; Vaessen LM; Maat AP; Balk AH; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2004 Apr; 25(4):619-26. PubMed ID: 15037281
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
Khedr MA; E Behairy B; Hussein ME; Marei AM; Nage SA; Zakaria HM
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1170-4. PubMed ID: 26148246
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients.
Shiina M; Kobayashi K; Kobayashi T; Kondo Y; Ueno Y; Shimosegawa T
J Gastroenterol; 2006 Aug; 41(8):758-64. PubMed ID: 16988764
[TBL] [Abstract][Full Text] [Related]
12. Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C.
Ma L; Zhou Y; Zhang Y; Li Y; Guo Y; He Y; Wang J; Lian J; Hao C; Moorman JP; Yao ZQ; Zhou Y; Jia Z
Immunology; 2014 Dec; 143(4):670-8. PubMed ID: 24965710
[TBL] [Abstract][Full Text] [Related]
13. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function.
Gerl V; Lischka A; Panne D; Grossmann P; Berthold R; Hoyer BF; Biesen R; Bruns A; Alexander T; Jacobi A; Dörner T; Burmester GR; Radbruch A; Hiepe F
Ann Rheum Dis; 2010 Jul; 69(7):1370-7. PubMed ID: 19854711
[TBL] [Abstract][Full Text] [Related]
14. Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy.
Tsubouchi E; Akbar SM; Murakami H; Horiike N; Onji M
Clin Exp Immunol; 2004 Aug; 137(2):417-23. PubMed ID: 15270861
[TBL] [Abstract][Full Text] [Related]
15. The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients.
Sacchi A; Agrati C; D'Offizi G; Vlassi C; Rozera G; Abbate I; Capobianchi MR; Martini F
Clin Immunol; 2011 Feb; 138(2):178-86. PubMed ID: 21130688
[TBL] [Abstract][Full Text] [Related]
16. Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy.
Liang CC; Liu CH; Lin YL; Liu CJ; Chiang BL; Kao JH
J Med Virol; 2011 Jul; 83(7):1212-20. PubMed ID: 21567425
[TBL] [Abstract][Full Text] [Related]
17. Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.
Pelletier S; Bédard N; Said E; Ancuta P; Bruneau J; Shoukry NH
J Virol; 2013 Jun; 87(12):6769-81. PubMed ID: 23576504
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients.
Sacchi A; Tumino N; Turchi F; Refolo G; Fimia G; Ciccosanti F; Montalbano M; Lionetti R; Taibi C; D'Offizi G; Casetti R; Bordoni V; Cimini E; Martini F; Agrati C
Clin Immunol; 2017 Oct; 183():82-90. PubMed ID: 28736275
[TBL] [Abstract][Full Text] [Related]
19. Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infection.
Doyle EH; Rahman A; Aloman C; Klepper AL; El-Shamy A; Eng F; Rocha C; Kim S; Haydel B; Florman SS; Fiel MI; Schiano T; Branch AD
PLoS Pathog; 2019 Jul; 15(7):e1007935. PubMed ID: 31356648
[TBL] [Abstract][Full Text] [Related]
20. Impaired CCR7 expression on plasmacytoid dendritic cells of HIV-infected children and adolescents with immunologic and virologic failure.
Desai S; Chaparro A; Liu H; Haslett P; Arheart K; Scott G; Pahwa R; Pahwa S
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):501-7. PubMed ID: 17468665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
